Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03459755

Evaluating Race Specific AGE Accumulation As a Behavioral Biomarker Prostate Cancer Survivors

Evaluating Race Specific AGE Accumulation As a Behavioral Biomarker That Can Reflect Optimal Health in Prostate Cancer Survivors

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Medical University of South Carolina · Academic / Other
Sex
Male
Age
45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to show that reduction in advanced glycation end-products (AGEs) is associated with the beneficial regulation of receptor for AGE (RAGE) mediated tumor response which may correlate with improved quality of life in PCa survivors. AGEs are produced by the body and are affected by lifestyle, weight and diet.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPhysical ActivityPatients will have a baseline assessment by undergoing a maximal exercise testing protocol. For 12 weeks, patients will participate in an exercise session 3 days per week The patient will then enter a 12 week "Step Down" program in which the number of sessions is decreased to every week, then every 3 weeks. After the second 12-week period, the patient will enter a 28-week follow up period of unsupervised exercise.

Timeline

Start date
2019-11-27
Primary completion
2019-11-27
Completion
2019-11-27
First posted
2018-03-09
Last updated
2024-09-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03459755. Inclusion in this directory is not an endorsement.